Lapatinib Increases Overall Survival in Metastatic Breast Cancer Patients With HER2-Positive Circulating Tumor Cells

/PRNewswire/ -- A new study shows that lapatinib, a drug used for the treatment of metastatic HER2-positive cancer, is associated with improved overall...

Related Keywords

Washington ,United States ,Molly Polen ,Christine Delong ,Association For Diagnostics Laboratory Medicine ,Laboratory Medicine ,Clinical Chemistry ,Association For Diagnostics Amp Laboratory Medicine Adlm ,